Decoy Therapeutics is trading at $4.43 (+7.79%) in active morning trading, moving higher despite a lack of fresh company-specific news or fundamental catalysts.
- The move appears to be a sentiment-driven rebound following a period of high volatility and a sharp selloff on July 27.
- The price action aligns with broader market strength, as the S&P 500, Nasdaq, and Dow are all trading higher today.
- No earnings releases or major corporate events have been reported in the current news flow to account for the gain.